Medtech Insights

The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by the growing number of procedures in which in biosurgical agents are used,…

The European large-joint reconstructive implant market is poised for long-term growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants, as well as…

Driven by the increasing prevalence of ear, nose, and throat disease and patient awareness of ENT procedures in this region, the Asia Pacific ENT device market will continue to expand through 2033…

The Latin American PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and IVL, as well…

The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…

The biosurgical agent market in the US will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats,…

The Latin American sports medicine device market will expand through 2033, driven by continued growth in underpenetrated procedures, the introduction of innovative devices, and improved physician…

The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs…

The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…

The European ENT device market will grow marginally over the forecast period, driven primarily by the faster-growing balloon dilation device and nasal packing segments. Slight FESS procedure volume…

The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…

The European neurovascular device market will see strong growth through 2033. New device launches, increasing adoption of innovative devices backed by favorable clinical data, and rising…